SB05
Pancreatic Cancer (EndoTAG®‑1) / Triple‑Negative Breast Cancer
Phase 3Active
Key Facts
Indication
Pancreatic Cancer (EndoTAG®‑1) / Triple‑Negative Breast Cancer
Phase
Phase 3
Status
Active
Company
About SynCore Biotechnology
Taiwan‑based public biotech advancing oncology, ophthalmology and dermatology pipelines with Phase‑3 assets.
View full company profile